A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Victor Moyo, MD
Merrimack Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Center for Cancer Care
Glendale, Arizona, United States
- Pinnacle Oncology
Scottsdale, Arizona, United States
- Comprehensive Blood and Cancer Center
Bakersfield, California, United States
- Wilshire Oncology Medical Group
Corona, California, United States
- North County Oncology
Oceanside, California, United States
- Central Coast Medical Oncology
Santa Maria, California, United States
- Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
- Carolinas Medical Center/blumenthal Cancer Center
Charlotte, North Carolina, United States
- Promedica Health System, Inc.
Toledo, Ohio, United States
- Chattanooga Gyn Oncology
Chattanooga, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2011
- Primary completion
- 30 Sept 2013
- Completion
- 30 Jun 2015
- Last update posted
- 12 May 2016
- Registered enrollment
- 223
- Registry id
- NCT01447706
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.